AU2022213009A1 - Treatment of sleep apnea with cbd - Google Patents

Treatment of sleep apnea with cbd Download PDF

Info

Publication number
AU2022213009A1
AU2022213009A1 AU2022213009A AU2022213009A AU2022213009A1 AU 2022213009 A1 AU2022213009 A1 AU 2022213009A1 AU 2022213009 A AU2022213009 A AU 2022213009A AU 2022213009 A AU2022213009 A AU 2022213009A AU 2022213009 A1 AU2022213009 A1 AU 2022213009A1
Authority
AU
Australia
Prior art keywords
cbd
sleep
patients
dee
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022213009A
Other languages
English (en)
Inventor
Donna Gutterman
Joseph Palumbo
Terri Sebree
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harmony Biosciences Management Inc
Original Assignee
Harmony Biosciences Management Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harmony Biosciences Management Inc filed Critical Harmony Biosciences Management Inc
Publication of AU2022213009A1 publication Critical patent/AU2022213009A1/en
Assigned to HARMONY BIOSCIENCES MANAGEMENT, INC. reassignment HARMONY BIOSCIENCES MANAGEMENT, INC. Amend patent request/document other than specification (104) Assignors: ZYNERBA PHARMACEUTICALS, INC.
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU2022213009A 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd Pending AU2022213009A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
US63/142,835 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (1)

Publication Number Publication Date
AU2022213009A1 true AU2022213009A1 (en) 2023-08-17

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022213009A Pending AU2022213009A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Country Status (11)

Country Link
US (1) US20240307418A1 (https=)
EP (1) EP4284349A1 (https=)
JP (1) JP2024505212A (https=)
KR (1) KR20230137404A (https=)
CN (1) CN116829135A (https=)
AU (1) AU2022213009A1 (https=)
CA (1) CA3206508A1 (https=)
IL (1) IL304827A (https=)
JO (1) JOP20230169A1 (https=)
MX (1) MX2023008876A (https=)
WO (1) WO2022162621A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2627344A (en) * 2022-12-16 2024-08-21 Kingdom Therapeutics Ltd Cannabinoid based therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2760460C (en) 2009-04-28 2019-04-02 Alltranz Inc. Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
BR112019026877A2 (pt) * 2017-06-19 2020-06-30 Zelda Therapeutics Operations Pty Ltd composições para distúrbios do sono e tratamentos do mesmo
IL278548B2 (en) * 2018-05-11 2025-07-01 Rhodes Tech Inc Pharmaceutical preparations containing dronabinol and sprays containing the same pharmaceutical preparations
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
BR112022004175A2 (pt) * 2019-09-17 2022-05-31 Zynerba Pharmaceuticals Inc Tratamento de encefalopatia de syngap1

Also Published As

Publication number Publication date
EP4284349A1 (en) 2023-12-06
MX2023008876A (es) 2023-09-12
CN116829135A (zh) 2023-09-29
KR20230137404A (ko) 2023-10-04
WO2022162621A1 (en) 2022-08-04
JOP20230169A1 (ar) 2023-07-27
IL304827A (en) 2023-09-01
CA3206508A1 (en) 2022-08-04
JP2024505212A (ja) 2024-02-05
US20240307418A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
US12508270B2 (en) Treatment of behavioral impairment in developmental and epileptic encephalopathy
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
US20240009210A1 (en) Cannabidiol for the Treatment of Refractory Seizures
WO2019058261A1 (en) TRANSDERMAL SYNTHETIC CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS
US20260076984A1 (en) Treatment of behavioral impairment in developmental and epileptic encephalopathy
US20240307418A1 (en) Treatment of sleep apnea with cbd
AU2023251986A1 (en) Treatment of seizure disorders
CN116782891A (zh) 大麻二酚对难治性癫痫发作的治疗
Sixel-Döring et al. TL-098 POLYSOMNOGRAPHICALLY VALIDATED REM SLEEP BEHAVIOUR DISORDER IN RESTLESS LEGS SYNDROME: FREQUENCY AND ASSOCIATED FACTORS
Ondo Pathophysiology, Associations, and Consequences of Sleep-Related Movement Disorders
Vinogradov et al. Insomnia and Sleep-Related Breathing Disorders: New Risk Factors for Ischemic Stroke
Pereira Jr et al. TL-094 IMBALANCE BETWEEN THYROID HORMONES AND THE DOPAMINERGIC SYSTEM MIGHT BE CENTRAL TO THE PATHOPHYSIOLOGY OF RESTLESS LEGS SYNDROME: A HYPOTHESIS

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: HARMONY BIOSCIENCES MANAGEMENT, INC.

Free format text: FORMER NAME(S): ZYNERBA PHARMACEUTICALS, INC.